GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MEDITERA TIBBI MALZEME SANAYI VE TICARET AS (IST:MEDTR) » Definitions » PEG Ratio

MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) PEG Ratio : 0.76 (As of Dec. 13, 2024)


View and export this data going back to 2021. Start your Free Trial

What is MEDITERA TIBBI MALZEMENAYI VE TICARET AS PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's PE Ratio without NRI is 38.01. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's 5-Year EBITDA growth rate is 50.10%. Therefore, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's PEG Ratio for today is 0.76.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for MEDITERA TIBBI MALZEMENAYI VE TICARET AS's PEG Ratio or its related term are showing as below:

IST:MEDTR' s PEG Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0.82
Current: 0.76


During the past 6 years, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's highest PEG Ratio was 0.82. The lowest was 0.00. And the median was 0.00.


IST:MEDTR's PEG Ratio is ranked better than
79.45% of 253 companies
in the Medical Devices & Instruments industry
Industry Median: 1.92 vs IST:MEDTR: 0.76

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


MEDITERA TIBBI MALZEMENAYI VE TICARET AS PEG Ratio Historical Data

The historical data trend for MEDITERA TIBBI MALZEMENAYI VE TICARET AS's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS PEG Ratio Chart

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial - - - - -

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MEDITERA TIBBI MALZEMENAYI VE TICARET AS's PEG Ratio

For the Medical Devices subindustry, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MEDITERA TIBBI MALZEMENAYI VE TICARET AS's PEG Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's PEG Ratio distribution charts can be found below:

* The bar in red indicates where MEDITERA TIBBI MALZEMENAYI VE TICARET AS's PEG Ratio falls into.



MEDITERA TIBBI MALZEMENAYI VE TICARET AS PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=38.013964313421/50.10
=0.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


MEDITERA TIBBI MALZEMENAYI VE TICARET AS  (IST:MEDTR) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


MEDITERA TIBBI MALZEMENAYI VE TICARET AS PEG Ratio Related Terms

Thank you for viewing the detailed overview of MEDITERA TIBBI MALZEMENAYI VE TICARET AS's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


MEDITERA TIBBI MALZEMENAYI VE TICARET AS Business Description

Traded in Other Exchanges
N/A
Address
Sokak No: 29 Tire Organize Sanayi, Ibni Melek OSB Mahallesi, TOSBI Yol 4, Bolgesi Tire, Izmir, TUR, 35900
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS is engaged in the manufacture of anesthesia and intensive care circuits, the installation, operation, and design of oncology drug preparation and delivery systems, production, sales, and technical service of infusion pumps and sets, and the manufacture of biocidal products.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Headlines

No Headlines